Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders

Veterinary Immunology and Immunopathology

Volumn 106, Issue 1-2, 2005, Pages 1-14

  Paillot, R ^a   Richard, S ^a   Bloas, F ^a   Piras, F ^a   Poulet, H ^a   Brunet, S ^a   Andreoni, C ^a   Juillard, V ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Apoptosis; Cellular immune response; FIV; General immune activation; IFN ; TNF

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; IMMUNOPATHOLOGY; IN VITRO STUDY; MALE; NONHUMAN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, VIRAL; APOPTOSIS; CAT DISEASES; CATS; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON TYPE II; LENTIVIRUS INFECTIONS; LYMPHOCYTE ACTIVATION; MALE; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA; VIREMIA;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS;

EID: 19344374703     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.12.023     Document Type: Article

References (30)

1. J.D. Ahlers, I.M. Belyakov, and J.A. Berzofsky Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines Curr. Mol. Med. 3 2003 285 301
2. P. Brazille, N. Dereuddre-Bosquet, C. Leport, P. Clayette, O. Boyer, J.L. Vilde, D. Dormont, and O. Benveniste Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients Clin. Exp. Immunol. 131 2003 304 311
3. J.J. Callanan, H. Thompson, S.R. Toth, B. O'Neil, C.E. Lawrence, B. Willett, and O. Jarrett Clinical and pathological findings in feline immunodeficiency virus experimental infection Vet. Immunol. Immunopathol. 35 1992 3 13
4. J.N. Flynn, S. Dunham, A. Mueller, C. Cannon, and O. Jarrett Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection Vet. Immunol. Immunopathol. 85 2002 159 170
5. D.H. Gebhard, J.L. Dow, T.A. Childers, J.I. Alvelo, M.B. Tompkins, and W.A. Tompkins Progressive expansion of an l-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats J. Infect. Dis. 180 1999 1503 1513
6. S. Giannecchini, P. Isola, O. Sichi, D. Matteucci, M. Pistello, L. Zaccaro, D. Del Mauro, and M. Bendinelli AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts J. Virol. 76 2002 6882 6892
7. J.V. Giorgi, L.E. Hultin, J.A. McKeating, T.D. Johnson, B. Owens, L.P. Jacobson, R. Shih, J. Lewis, D.J. Wiley, J.P. Phair, S.M. Wolinsky, and R. Detels Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage J. Infect. Dis. 179 1999 859 870
8. P.A. Goepfert, A. Bansal, B.H. Edwards, G.D. Ritter Jr., I. Tellez, S.A. McPherson, S. Sabbaj, and M.J. Mulligan A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon J. Virol. 74 2000 10249 10255
9. M.L. Gougeon, H. Lecoeur, F. Boudet, E. Ledru, S. Marzabal, S. Boullier, R. Roue, S. Nagata, and J. Heeney Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype J. Immunol. 158 1997 2964 2976
10. A.L. Guiot, D. Rigal, and G. Chappuis Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: pharmacological modulation in vitro Int. J. Immunopharmacol. 19 1997 167 179
11. Y. Inoshima, Y. Ikeda, M. Kohmoto, M.R. Pecoraro, M. Shimojima, Y. Shimojima, G. Inada, Y. Kawaguchi, K. Tomonaga, T. Miyazawa, and T. Mikami Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus J. Vet. Med. Sci. 58 1996 925 927
12. J.A. Karlas, K.H. Siebelink, M.A. Peer, W. Huisman, A.M. Cuisinier, G.F. Rimmelzwaan, and A.D. Osterhaus Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection J. Gen. Virol. 80 Pt 3 1999 761 765
13. S. Kostense, G.S. Ogg, E.H. Manting, G. Gillespie, J. Joling, K. Vandenberghe, E.Z. Veenhof, D. van Baarle, S. Jurriaans, M.R. Klein, and F. Miedema High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function Eur. J. Immunol. 31 2001 677 686
14. L.A. Kraus, W.G. Bradley, R.W. Engelman, K.M. Brown, R.A. Good, and N.K. Day Relationship between tumor necrosis factor alpha and feline immunodeficiency virus expressions J. Virol. 70 1996 566 569
15. Q. Leng, G. Borkow, Z. Weisman, M. Stein, A. Kalinkovich, and Z. Bentwich Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection J. Acq. Immun. Def. Synd. 27 2001 389 397
16. C.M. Leutenegger, D. Klein, R. Hofmann-Lehmann, C. Mislin, U. Hummel, J. Boni, F. Boretti, W.H. Guenzburg, and H. Lutz Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system J. Virol. Methods 78 1999 105 116
17. Y. Liang, L.C. Hudson, J.K. Levy, J.W. Ritchey, W.A. Tompkins, and M.B. Tompkins T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats J. Infect. Dis. 181 2000 564 575
18. P.F. McKay, J.E. Schmitz, D.H. Barouch, M.J. Kuroda, M.A. Lifton, C.E. Nickerson, D.A. Gorgone, and N.L. Letvin Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys J. Immunol. 168 2002 332 337
19. H. McShane Prime-boost immunization strategies for infectious diseases Curr. Opin. Mol. Ther. 4 2002 23 27
20. T. Mizuno, Y. Goto, K. Baba, K. Masuda, K. Ohno, and H. Tsujimoto TNF-alpha-induced cell death in feline immunodeficiency virus-infected cells is mediated by the caspase cascade Virology 287 2001 446 455
21. N.J. O'Neil-Andersen, and D.A. Lawrence Differential modulation of surface and intracellular protein expression by T cells after stimulation in the presence of monensin or brefeldin A Clin. Diagn. Lab. Immunol. 9 2002 243 250
22. A. Poli, M. Pistello, M.A. Carli, F. Abramo, G. Mancuso, E. Nicoletti, and M. Bendinelli Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus J. Neurovirol. 5 1999 465 473
23. J. Richardson, S. Broche, S. Baud, T. Leste-Lasserre, F. Femenia, D. Levy, A. Moraillon, G. Pancino, and P. Sonigo Lymphoid activation: a confounding factor in AIDS vaccine development? J. Gen. Virol. 83 2002 2515 2521
24. J.E. Schmitz, M.A. Forman, M.A. Lifton, O. Concepcion, K.A. Reimann Jr., C.S. Crumpacker, J.F. Daley, R.S. Gelman, and N.L. Letvin Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals Blood 92 1998 198 206
25. K.H. Siebelink, E. Tijhaar, R.C. Huisman, W. Huisman, A. de Ronde, I.H. Darby, M.J. Francis, G.F. Rimmelzwaan, and A.D. Osterhaus Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines J. Virol. 69 1995 3704 3711
26. W. Song, E.W. Collisson, P.M. Billingsley, and W.C. Brown Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats J. Virol. 66 1992 5409 5417
27. A.E. Sousa, J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R.M. Victorino CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load J. Immunol. 169 2002 3400 3406
28. M.B. Tompkins, M.E. Bull, J.L. Dow, J.M. Ball, E.W. Collisson, B.J. Winslow, A.P. Phadke, T.W. Vahlenkamp, and W.A. Tompkins Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis J. Infect. Dis. 185 2002 1077 1093
29. A. Trautmann, B. Ruckert, P. Schmid-Grendelmeier, E. Niederer, E.B. Brocker, K. Blaser, and C.A. Akdis Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation Immunology 108 2003 305 312
30. N. Watanabe, S.C. De Rosa, A. Cmelak, R. Hoppe, L.A. Herzenberg, and M. Roederer Long-term depletion of naive T cells in patients treated for Hodgkin's disease Blood 90 1997 3662 3672